Collins T F, Black T N, Rorie J I, Sprando R L, Ruggles D I
Center for Food Safety and Applied Nutrition, U.S Food and Drug Administration, Laurel, Maryland 20708, USA.
Toxicol Ind Health. 1996 Jan-Feb;12(1):45-57. doi: 10.1177/074823379601200102.
The pyrazolone dye Orange B was given by gavage to pregnant Osborne-Mendel rats throughout gestation. Dose levels of 0, 15, 30, 100, 200, 400, or 700 mg/kg body weight were given daily. On gestation day 20, the females were killed and cesarean sections were performed. Feed consumption and maternal weight gain were not affected. No dose-related changes were seen in maternal clinical findings, implantations, fetal viability, or fetal size (weight and length). No compound-related effects were seen in sternebral development. No dose-related effect was seen in the incidence of skeletal variations in fetuses or in the number of litters containing fetuses with skeletal variations. Skeletal development, as measured by the average number of ossified vertebrae, was similar in all groups. No compound-related effects were seen in soft-tissue development.
在整个妊娠期,通过灌胃给怀孕的奥斯本-孟德尔大鼠服用吡唑啉酮染料橙B。每天给予的剂量水平为0、15、30、100、200、400或700毫克/千克体重。在妊娠第20天,处死雌性大鼠并进行剖宫产。饲料消耗和母体体重增加未受影响。在母体临床检查结果、着床、胎儿活力或胎儿大小(体重和体长)方面未观察到与剂量相关的变化。在胸骨发育方面未观察到与化合物相关的影响。在胎儿骨骼变异的发生率或含有骨骼变异胎儿的窝数方面未观察到与剂量相关的影响。通过平均骨化椎骨数衡量的骨骼发育在所有组中相似。在软组织发育方面未观察到与化合物相关的影响。